OakLabs Logo
Lab Services

About OakLabs


  • OakLabs’ core business are predictive biomarkers of superior accuracy for drugs in clinical trial or on the market
  • The company was founded in 2011 by biochemist Martina Schad, Ph.D. and quantum physicist Jim Kallarackal, Ph.D
  • The headquarters are located near Berlin, Germany
  • OakLabs’ unique approach includes proprietary, computationally intensive, highly parallelized algorithms from artificial intelligence


One vital component for success is the fact that OakLabs successfully employs dedicated proprietary algorithms inspired by concepts from artificial intelligence. We compute exact solutions rather than approximations and massively parallelize our algorithms to reduce the required core year computing time to days. Quantum computing further accelerates our computations.

The company combines multiple molecular markers to signatures and achieves superior accuracies compared to single biomarkers. They have proven to provide remarkable results in regard to sensitivity and specificity of predictive single drug biomarkers and help to prevent lack of efficacy failures in clinical trials.


OakLabs is lead by the two founders Martina Schad, Ph.D., and Jim Kallarackal, Ph.D.

Dr. Martina Schad (Founder & CEO)

Martina completed her PhD at the Max Planck Institute in Potsdam. Her ambitious goals led her to the National Institute of Health (NIH) as well as the Pacific Northwest National Laboratories (PNNL) in the USA. There she achieved major innovations in single cell analysis.

She headed the department of molecular data acquisition of two biotech companiesin Berlin. At OakLabs she manages partnering and cooperation projects. Her deep understanding of their uniqueness enables her to translate challenges in life sciences to OakLabs’ superior technology.

Dr. Jim Kallarackal (Founder & CEO)
Quantum physicist

Jim has extensively studied and enhanced Monte Carlo algorithms during his PhD in quantum field theory. He is an expert in data analysis & simulations.

During his studies of theoretical physics at RWTH Aachen, he successfully founded a software company for clinical data management and diagnostics using machine learning in 2005. After finishing his PhD, Jim has gained about nine years of industrial management experience at OakLabs.